The White House announced on Thursday that it will impose a 100% tariff on certain imported pharmaceuticals. According to Ming Pao, this move is aimed at pressuring pharmaceutical companies to expand their production within the United States. The decision includes several key exemptions to mitigate potential impacts on the healthcare sector. The administration's strategy seeks to bolster domestic manufacturing and reduce dependency on foreign drug supplies.